AEROCLAV-625 is listed with Amoxicillin (500 mg), a penicillin-class antibiotic. Amoxicillin acts by inhibiting bacterial cell-wall synthesis and has bactericidal activity against susceptible bacteria. Its use is guided by the likely or confirmed bacterial cause, local antimicrobial susceptibility patterns, and clinical assessment. Prescribers should consider the patient’s clinical context and applicable antimicrobial stewardship guidance when selecting antibiotic therapy.
Amoxicillin combined with clavulanic acid is commonly prescribed to treat various bacterial infections. Clavulanic acid is a beta-lactamase inhibitor that prevents certain bacteria from breaking down amoxicillin, making the combination more effective.
Indications for Aeroclav 625:
Respiratory Tract Infections:
Skin and Soft Tissue Infections:
Urinary Tract Infections:
Bone and Joint Infections:
Dental Infections:
Intra-abdominal Infections:
Amoxicillin is used in the treatment of infections caused by susceptible bacteria. Selection of antibiotic therapy should be based on clinical assessment and relevant antimicrobial susceptibility guidance.
Verified product information, formulation specifications, and commercial supply pathways for registered healthcare professionals, institutions, and trade partners.
Review verified active composition, strength, dosage form, and packaging details on this page.
View SpecificationsRequest formulation literature, technical specifications, or product communication from our commercial team.
Submit Product EnquiryConnect regarding institutional supply requirements, trade distribution, or third-party contract manufacturing.
Commercial EnquiryThis product information is intended for registered healthcare professionals, medical practitioners, and authorized distribution partners. Product manufacturing is coordinated through eligible facility partners under applicable licences.
Request information about AEROCLAV -625 for professional use.